They analyze the 2020 KDIGO clinical practice guideline, summarized in Annals of Internal Medicine in March, and some additional recent studies on the subject. ... Each Annals On Call podcast features Dr. Centor discussing and debating a clinically
https://diabetes.acponline.org/archives/2020/11/13/7.htm. A new summary of the guideline from Kidney Disease: Improving Global Outcomes (KDIGO) highlights important points for clinicians, including recommendations about ... A summary of a recent clinical
https://diabetes.acponline.org/archives/2019/11/08/6.htm. Current evidence on prevention and treatment of type 2 diabetes is summarized in a new In the Clinic article targeted at ... An In the Clinic article in the Nov. 5 Annals of Internal Medicine
A synopsis, published by Annals of Internal Medicine on Sept. 1, reviewed recommendations on pharmacologic approaches to glycemic treatment from the latest version of the American Diabetes Association (ADA) Standards of ... Experts from Mark's Hospital
Patients with polymyalgia rheumatic and type 2 diabetes had improvement in rheumatic symptoms and laboratory measures after achieving good glycemic control, according to a series of three cases. ... The case series, published as a letter by Annals of
Leslie, MD, FACP. In an Annals On Call podcast posted March 17, host Robert M. ... Each Annals On Call podcast features Dr. Centor discussing and debating a clinically influential article published in Annals of Internal Medicine with a guest expert.
The report, published as a letter by Annals of Internal Medicine on Aug. ... He also had bilateral sensorineural hearing loss diagnosed at age 15 years, which was determined to be part of maternally inherited diabetes and deafness (MIDD).
The study was funded by The European Foundation for the Study of Diabetes, supported by an unrestricted educational grant from AstraZeneca. ... Results were published by Annals of Internal Medicine on June 30.
Results were published by Annals of Internal Medicine on April 23. ... Incidence of preterm birth increased with HbA1c level, from 13.2% with HbA1c level below 6.5% (adjusted risk ratio [aRR] vs.
once daily (with a goal of a dose increase to 400 mg) or matching placebo. ... Results were published online on June 22 by Annals of Internal Medicine.